Propionato de Clobetasol Uses, Dosage, Side Effects and more
Propionato de Clobetasol is under investigation for the treatment of Scleroderma. Propionato de Clobetasol has been investigated for the prevention of Psoriasis and Cutaneous Atrophy Due to Corticosteroids.
| Attribute | Details |
|---|---|
| Trade Name | Propionato de Clobetasol |
| Availability | Prescription only |
| Generic | Clobetasol |
| Clobetasol Other Names | Clobetasol |
| Related Drugs | Humira, Cosentyx, Dupixent, prednisone, doxycycline, methotrexate, betamethasone topical, Remicade, Stelara, cyclosporine |
| Type | |
| Formula | C22H28ClFO4 |
| Weight | Average: 410.907 Monoisotopic: 410.166015296 |
| Groups | Approved, Experimental, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | Brazil |
| Last Updated: | January 7, 2025 at 1:49 am |
Disease Interaction
Moderate: diabetes, diaper rash, hyperadrenocorticism, infections, ocular toxicities
